
This Word Means: M4 carbine
A preliminary investigation into the deadly attack on tourists near Pahalgam has revealed that the terrorists opened fire with AK-47s, and more interestingly, American-made M4 carbines.
Why is this significant?
Russian-origin AKs are the weapon of choice for most militants, terrorists, and rebel groups around the world. Their simplicity, reliability, and affordability make them ideal for combatants with limited means, operating for long durations in difficult conditions without much logistics support.
American weapons do not fit this bill. In general, they require better training and upkeep to be effective, and are much more expensive — cons which do not always balance out the pros of them being lighter, more versatile, and more accurate.
This is what makes an M4 carbine a somewhat unlikely weapon in the hands of terrorists, especially in a part of the world where knock-off AKs are a dime a dozen. That the Pahalgam attackers carried M4s indicates they are highly sophisticated operatives, and not the run-of-the-mill disgruntled youth.
That said, it is not completely unheard of for terrorists to carry M4s, especially in the very recent past.
How did the terrorists obtain M4s?
There are two possible explanations for how the Pahalgam attackers got hold of M4 carbines.
The first is to do with the United States's exit from Afghanistan in 2021. At the time they pulled out from Kabul, the Americans had been fighting in the country for two decades. In the process, they had developed massive stockpiles of weapons in Afghanistan — much of which they left behind, ostensibly for the Afghan forces to use against the Taliban.
Of course, the Afghan resistance folded almost immediately after the American exit, leaving the Taliban with the weaponry left behind. While some of this the Taliban kept for itself, huge caches of guns and ammo were sold to the highest bidder in Afghanistan's busy arms markets. The beneficiaries: a motley collection of rebel groups, militias, tribal warlords, and, of course, terrorists.
The other explanation for how the terrorists got hold of weapons is more straightforward: they were supplied by the Pakistani state, presumably the ISI. Pakistan also has a decent stockpile of M4s, which is used by its special forces.
Why is the M4 carbine a lethal weapon?
Following the military adoption of the Armalite AR-15 as the M16 rifle in the 1960s, the United States spent two decades developing an effective carbine on the same platform. Carbines are essentially rifles which are lighter, and have a shorter barrel than a standard rifle. They are meant to be used by highly mobile units, or for urban warfare, and were originally developed as rifle-caliber arms for mounted units.
The M4 carbine was officially adopted by the US in 1994, and has since seen use by over 60 militaries around the world. Chambered in the 5.56×45mm NATO cartridge, the M4 can fire upto 950 rounds a minute, and has a maximum effective range of around 600 metres.
Weighing only 3.5 kilos (fully loaded), it is lighter than even most modern AKs with plastic magazines and stocks. And unlike older AKs, it comes with a built-in Picatinny rail, which allows for an assortment of attachments, from advanced telescopic and night vision sights, to laser guides, and even grenade launchers.
Military historian Chris McNabb refers to the M4 as 'one of the defining firearms of the 21st century.' (The M4 Carbine, 2021).

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Mint
14 minutes ago
- Mint
Trump talks tough on drug prices but his demands have softened
President Donald Trump appears to be easing up on his push to force drugmakers to cut their prices for U.S. patients, even as he ramps up the rhetoric he is deploying against the companies. The president on Thursday afternoon posted letters to his Truth Social platform that the White House had sent to 17 large pharmaceutical and biotech companies, saying they each have until late September to cut certain U.S. prices, or else the administration will 'deploy every tool in our arsenal to protect American families." Drug stocks fell in response. The S&P 500 Pharmaceuticals industry group index was down 2.7% Thursday, while the S&P 500 was down 0.4%. Still, the new demands Trump made on Thursday appear to require far less from the companies than had been implied by an executive order on drug pricing the president signed two months ago. In May, the White House resurfaced a proposal from the first Trump administration that would peg prices paid for prescription medicines in the U.S. to the lowest prices paid in other wealthy countries, the so-called most-favored-nation price. An executive order signed May 12 ordered federal agencies to determine most-favored-nation prices for drugs. It laid out penalties if the companies didn't make 'significant progress" toward lowering U.S. pricing to those levels. The order suggested that the most-favored-nation prices would apply to all U.S. drugs, regardless of whether they were paid for by the federal government or private payers, and whether the drugs were new or had been on the market for years. The new letters posted Thursday make narrower demands. Trump told drugmakers they must lower the prices of drugs already on the market to most-favored-nation rates only for Medicaid, the health insurance program for low-income Americans paid for jointly by state governments and the federal government. Medicaid already pays a steeply discounted rate for drugs under pre-existing programs. For all other payers, including Medicare and commercial plans, Trump says the most-favored-nation rates should only apply to newly launched medicines. 'I think Trump is, in some ways, softening his tone on most favored nation," Raymond James healthcare policy analyst Chris Meekins told Barron's. 'Originally, he said the U.S. will get the best price that any other nation gets for all products. Now he's carving out specific categories." Meekins said that the new approach is potentially more realistic. 'Attempting to try to make sure the U.S. gets better prices on future products is something companies can work with the administration to try to do going forward," he said. Details about the plan remain scarce. The drug industry lobby group PhRMA, in a statement, criticized the effort. 'Importing foreign price controls would undermine American leadership, hurting patients and workers," said PhRMA senior vice president Alex Schriver in a statement. 'At a time when China is threatening to overtake the U.S. in biopharmaceutical leadership, we need to ensure America continues to be the most attractive place in the world to develop innovative medicines." Trump sent the letters to top executives at AbbVie, Bristol Myers Squibb, Novartis, Gilead Sciences, Pfizer, and other companies. In the letters to Pfizer and Regeneron, he crossed out the surnames of the companies' CEOs, Albert Bourla and Leonard Schleifer, and wrote in their first names by hand. Write to Josh Nathan-Kazis at


Hans India
14 minutes ago
- Hans India
Congress MP Shashi Tharoor Breaks Ranks With Rahul Gandhi Over Trump's 'Dead Economy' Remark
Congress MP Shashi Tharoor has publicly contradicted party colleague Rahul Gandhi's support for US President Donald Trump's characterization of India as a "dead economy," creating another visible fissure within the opposition party's leadership. Speaking to reporters on Friday, the Thiruvananthapuram parliamentarian firmly rejected Trump's economic assessment, stating simply that "this is not the case, and we all know it." His response directly countered Gandhi's endorsement of the American President's remarks made just one day earlier. Trump's inflammatory comments emerged this week as part of his broader criticism of India's relationship with Russia, where he declared indifference toward India-Russia cooperation and dismissed both nations as having "dead economies." The remarks accompanied his announcement of 25 percent tariffs on Indian goods effective August 1. Rahul Gandhi, serving as Leader of Opposition in the Lok Sabha, had embraced Trump's economic critique as validation of his criticism against the Modi government. Gandhi claimed that everyone except the Prime Minister and Finance Minister recognized India's economic struggles, alleging that the BJP had deliberately damaged the economy to benefit industrialist Gautam Adani. Tharoor's dissent represents the latest indication of growing tensions between the senior Congress leader and his party's official positions. Unlike Gandhi's harsh governmental criticism, Tharoor refrained from attacking the Modi administration while rejecting Trump's characterization. The government has strongly defended India's economic performance through Commerce Minister Piyush Goyal's parliamentary statements. Goyal emphasized India's status as the world's fastest-growing major economy and its trajectory toward becoming the third-largest global economy, while asserting that India would protect its national interests regarding US tariff implications. This disagreement compounds existing friction between Tharoor and Congress leadership, particularly regarding his public support for Operation Sindoor, which conflicts with the party's official stance. Tharoor has consistently prioritized national interests over party positioning, stating that "the nation comes before the party" when defending military operations. The rift deepened when the government appointed Tharoor to head the Operation Sindoor delegation to the United States without Congress party nomination. Sources indicate he declined participation in parliamentary debates on the operation, reportedly unwilling to contradict his established positions for party messaging purposes. This pattern of public disagreement highlights broader challenges within Congress regarding message discipline and ideological coherence, particularly when national security issues intersect with partisan political considerations.


New Indian Express
14 minutes ago
- New Indian Express
Pakistan issues fresh call for Afghans to leave country, thousands rush to border
QUETTA: Pakistan issued a new call on Friday for Afghans living in the southwest to leave the country, triggering thousands to rush to the border, officials said. Millions of Afghans have poured into Pakistan over the past several decades, fleeing successive wars, as well as hundreds of thousands who arrived after the return of the Taliban government in 2021. A deportation drive first launched in 2023 was renewed in April when Pakistan's government rescinded hundreds of thousands of residence permits for Afghans, threatening to arrest anyone who did not leave. "We have received directives from the home department to launch a fresh drive to repatriate all Afghans... in a respectful and orderly manner," Mehar Ullah, a senior government official in Quetta, the capital of Balochistan province, told AFP. The province borders Afghanistan and there are significant ties between the regions. On Friday, there were "around 4,000 to 5,000 people at the Chaman border" waiting to return, said Habib Bingalzai, a senior government official in Chaman.